FDA Draft Guidance Maps Payor Strategy For Psychedelics
By Kimberly Chew · July 22, 2026, 5:18 PM EDT
In June, the U.S. Food and Drug Administration issued its first revision to the guidance governing manufacturer communications with payors in eight years.[1]...
To view the full article, register now.